Corrigendum to "When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinoma." [Crit. Rev. Oncol. Hematol. 2026 May:221:105238.].

Authors

Sebastiano Buti, Betty Dalla Valle, Alessandro Acunzo, Pietro Tuttobene, Prisca Tamarozzi, Virginia Agnetti, Michele Maffezzoli

Published in

Critical reviews in oncology/hematology. Pages 105632. Oct 08, 2026. Epub Oct 08, 2026.

PMID:
42850095
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.